Finance

Beta
Lists
LENZ:NASDAQ
Lenz Therapeutics Inc
$6.76
-0.37%
(-0.025) 1D
Jun 10, 2:06:32 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LENZ...
Open
$6.72
High
$6.90
Low
$6.66
Mkt. cap
212.11M
Avg. vol.
818.22K
Volume
153.55K
52-wk high
$50.19
52-wk low
$6.52
EPS
-$3.59
Beta
0.58
Shares outstanding
31.35M
No. of employees
152
Open
$6.72
High
$6.90
Low
$6.66
Mkt. cap
212.11M
Avg. vol.
818.22K
Volume
153.55K
52-wk high
$50.19
52-wk low
$6.52
EPS
-$3.59
Beta
0.58
Shares outstanding
31.35M
No. of employees
152
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to LENZ in the past 3 months
Strong Buy
Buy
5
Hold
1
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for LENZ in the last 3 months.
Highest
Current $6.76
$60.00 (+786.92%)
Average
$32.20 (+375.98%)
Lowest
$12.00 (+77.38%)
News stories
From sources across the web
About Lenz Therapeutics Inc
CEO-
Employees152
Founded2013
HeadquartersSolana Beach, California, United States
SectorPharmaceutical industry
Websitelenz-tx.com
Last report
May 11, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$1.32 / -$1.07
-23.30%miss
Revenue / Est. (USD)
1.90M / 1.76M
+8.08%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.00M
12.50M
1.59M
1.90M
Cost of goods sold
-
-
418.00K
1.08M
Cost of revenue
-
-
418.00K
1.08M
Research and development expenses
9.06M
3.79M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.80M
27.60M
39.63M
44.96M
Operating expense
21.86M
31.39M
39.63M
44.96M
Total operating expenses
21.86M
31.39M
40.05M
46.04M
Operating income
-16.86M
-18.89M
-38.46M
-44.14M
Other non operating income
199.00K
-14.00K
-417.00K
3.00K
EBT including unusual items
-14.41M
-16.70M
-35.89M
-41.49M
EBT excluding unusual items
-14.41M
-16.70M
-35.89M
-41.49M
Income tax expense
500.00K
-
2.00K
-
Effective tax rate
-3.47%
-
-0.01%
-
Other operating expenses
-
-
-
-
Net income
-14.91M
-16.70M
-35.90M
-41.49M
Net profit margin
-298.24%
-133.60%
-2,260.45%
-2,182.43%
Earnings per share
-0.53
-0.59
-1.16
-1.32
Interest and investment income
2.25M
2.20M
2.99M
2.64M
Interest expense
-
-
-
-
Net interest expenses
2.25M
2.20M
2.99M
2.64M
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.84M
-18.76M
-38.36M
-44.02M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer